C-Reactive Protein and Cardiovascular Risk in the Metabolic Syndrome and Type 2 Diabetes: Controversy and Challenge Clinical Diabetes January 2007 25:16-22; doi:10.2337/diaclin.25.1.16
C-Reactive Protein and Cardiovascular Risk in the Metabolic Syndrome and Type 2 Diabetes: Controversy and Challenge Clinical Diabetes January 2007 25:16-22; doi:10.2337/diaclin.25.1.16
Development and Evolution of a Primary Care-Based Diabetes Disease Management Program Clinical Diabetes January 2007 25:31-35; doi:10.2337/diaclin.25.1.31
Development and Evolution of a Primary Care-Based Diabetes Disease Management Program Clinical Diabetes January 2007 25:31-35; doi:10.2337/diaclin.25.1.31
Rosiglitazone Reduced the Incidence of Diabetes in Patients With Impaired Glucose Tolerance Clinical Diabetes January 2007 25:23-24; doi:10.2337/diaclin.25.1.23
Development and Evolution of a Primary Care-Based Diabetes Disease Management Program Clinical Diabetes January 2007 25:31-35; doi:10.2337/diaclin.25.1.31
Development and Evolution of a Primary Care-Based Diabetes Disease Management Program Clinical Diabetes January 2007 25:31-35; doi:10.2337/diaclin.25.1.31